These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2127238)

  • 21. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE; Mueller RA; Breese GA
    Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
    Allen SM; Freeman JN; Davis WM
    Pharmacol Biochem Behav; 1998 Feb; 59(2):327-30. PubMed ID: 9476977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR; Baumeister A; Napier TC; Frye GD; Mueller RA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPRT-APRT-deficient mice are not a model for lesch-nyhan syndrome.
    Engle SJ; Womer DE; Davies PM; Boivin G; Sahota A; Simmonds HA; Stambrook PJ; Tischfield JA
    Hum Mol Genet; 1996 Oct; 5(10):1607-10. PubMed ID: 8894695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.
    Baumeister AA; Frye GD
    Neurosci Biobehav Rev; 1985; 9(2):169-78. PubMed ID: 3925393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study.
    Towle AC; Criswell HE; Maynard EH; Lauder JM; Joh TH; Mueller RA; Breese GR
    Pharmacol Biochem Behav; 1989 Oct; 34(2):367-74. PubMed ID: 2576138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monkeys with unilateral ventromedial tegmental lesions of the brain stem: models for Parkinson's disease and Lesch-Nyhan syndrome.
    Goldstein M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):311-8. PubMed ID: 2501825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models of Lesch-Nyhan syndrome.
    Jinnah HA; Gage FH; Friedmann T
    Brain Res Bull; 1990 Sep; 25(3):467-75. PubMed ID: 2292045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome.
    Finger S; Heavens RP; Sirinathsinghji DJ; Kuehn MR; Dunnett SB
    J Neurol Sci; 1988 Sep; 86(2-3):203-13. PubMed ID: 3221240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiopathology of neurological signs of hypoxanthine-guanine phosphoribosyltransferase deficiency].
    Torres-Jiménez R; Mateos-Antón F; Arcas-Martínez J; Pascual-Castroviejo I; García-Puig J
    Rev Neurol; 1998 Dec; 27(160):1050-4. PubMed ID: 9951034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.
    Kuehn MR; Bradley A; Robertson EJ; Evans MJ
    Nature; 1987 Mar 19-25; 326(6110):295-8. PubMed ID: 3029599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.